Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid LeukemiaKevin Lin, Kris C. Wood, Peter Winter et al.|Scientific Reports|2016Cited by 178
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug SensitivityKevin Lin, Kris C. Wood, Abigail Xie et al.|Cell Metabolism|2019Cited by 112
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancerKevin Lin, Kris C. Wood, Justine C. Rutter et al.|Nature Genetics|2020Cited by 91
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Justine C. Rutter et al.|Nature Cancer|2022Cited by 42